Value-Based Health Care Headlines National Pharmacy Meeting in Dallas


 Managed Care Pharmacists to Address “Changing the Way We Pay for Health Care” – Including Benefits to Patients, Payers and Providers and Gene Therapy Reimbursement; Dallas-Area Business Leaders to Present 

More than 2,200 managed care professionals will convene Oct. 16-19 at the Gaylord Texan Hotel and Convention Center, Grapevine, Texas, to take on two of the hottest issues facing health care: The shift towards paying for value over volume and how it benefits patients, providers and payers, and the spectacular promise of new gene therapies – and the fierce challenges in paying for them.

The Academy of Managed Care Pharmacy’s Nexus 2017: Changing Way We Pay for Health Care fall conference begins Mon. Oct. 19 with the AMCP Foundation symposium (below), followed Tuesday by panel discussion on paying for cures and, through Oct. 19, more than 30 education sessions.


America’s Pipeline Conundrum: Paying for Cures 

Tue., Oct. 17 | 2:30pm – 4:00pm
Moderator Alan Weil, Editor in Chief of Health Affairs, will lead discussion on the foundational questions: “Will the system figure out a way to pay for cures? And if so, how?” From mortgages to warranties, value-based contacts to installment plans, our panelists will address the upsides and the challenges of each. Panelists include:

  • Dallas-area presenters include Paul Hain, MD, Regional President of Blue Cross, Blue Shield of Texas, and Kembre Roberts, Director of Wellness at Southwest Airlines. 
  • Keynote speaker is Alan Balch, PhD, CEO of the Patient Advocate Foundation. 
  • Moderating is Clifford Goodman, PhD, MS, Senior Vice President and Director, Center for Comparative Effectiveness Research at The Lewin Group. He served as Chair of MEDCAC (Medicare Evidence Development and Coverage Advisory Committee). 

AMCP Foundation Symposium “Value-Based Health Care: Identifying Benefits for Patients, Providers and Payers”

Monday, October 16 | 11:30 am – 5:00 pm
Concept of value encompasses many things, besides the cost element. Presenters from health plans, think tanks and patient groups will identify the benefits for patients, providers and payers.

  • Steve Miller, SVP and CMO of Express Scripts
  • Jane Barlow, senior advisor to MIT Center for Biomedical Innovation
  • J.D. Kleinke, economist and fellow of the American Enterprise Institute
  • Tim Miller, president and CEO of Dallas-based Abeona Therapeutics


Gaylord Texan Hotel & Convention Center/1501 Gaylord Trail, Grapevine, TX